Robin J Parks

5PUBLICATIONS
3CO-AUTHORS
Molecular targetsAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2020
Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.

Joshua Del Papa, Ryan G Clarkin, Robin J Parks

|Jun 12, 2020
Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.

Kathy L Poulin, Emily R McFall, Grace Chan

|Jul 13, 2017
Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells.

Bratati Saha, Robin J Parks

|Jul 12, 2017
mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells.

Walaa Eid, Kristin Dauner, Kevin C Courtney

Pageof 1

Frequent Collaborators

1 joint publications

Alexander Sorisky

1 joint publications

Xiaohui Zha

1 joint publications

Ryan G Clarkin